Abstract
Coronary artery disease incidence and mortality are far lower in Japan as compared to Western countries, Japanese guideline for LDL cholesterol is stricter than those of Western countries for the purpose of maintaining low CAD incidence and mortality. Therefore, improve lifestyle habits becomes a basic treatment strategy. In case of drug use, side effects should be carefully checked. The revised guideline 2012 is based on the concept of absolute risk. Non HDL cholesterol will be evaluated secondarily in hypertriglyceridemia, and management of risk factore other than LDL cholesterol will be emphasized.
